Mild/Moderate Asthma Network in Italy (MANI): a long-term observational study

References

• Bloom CI, Nissen F, Douglas IJ, Smeeth L, Cullinan P, Quint JK. Exacerbation risk and characterisation of the UK’s asthma population from infants to old age. Thorax. 2018;73(4):313–320. doi:https://doi.org/10.1136/thoraxjnl-2017-210650.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, Cullinan P, Custovic A, Ducharme FM, Fahy JV, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350–400. doi:https://doi.org/10.1016/S0140-6736(17)30879-6.
   PubMed Web of Science ®Google Scholar
• Fuchs O, Bahmer T, Rabe KF, von Mutius E. Asthma transition from childhood into adulthood. Lancet Respir Med. 2017;5(3):224–234. doi:https://doi.org/10.1016/S2213-2600(16)30187-4.
   PubMed Web of Science ®Google Scholar
• Lange P. Persistent airway obstruction in asthma. Am J Respir Crit Care Med. 2013;187(1):1–2. doi:https://doi.org/10.1164/rccm.201211-1966ED.
   PubMed Web of Science ®Google Scholar
• Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Rebuck AS. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992;326(8):501–506. doi:https://doi.org/10.1056/NEJM199202203260801.
   PubMed Web of Science ®Google Scholar
• Reddel HK, Busse WW, Pedersen S, Tan WC, Chen YZ, Jorup C, Lythgoe D, O’Byrne PM. Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START study. Lancet. 2017;389(10065):157–166. doi:https://doi.org/10.1016/S0140-6736(16)31399-X.
   PubMed Web of Science ®Google Scholar
• GINA. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2020. Available from: https://ginasthma.org/ [last accessed 20 December 2020].
   Google Scholar
• Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343(5):332–336. doi:https://doi.org/10.1056/NEJM200008033430504.
   PubMed Web of Science ®Google Scholar
• Ernst P, Spitzer WO, Suissa S, Cockcroft D, Habbick B, Horwitz RI, Boivin JF, McNutt M, Buist AS. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA. 1992;268(24):3462–3464.
   PubMed Web of Science ®Google Scholar
• Volmer T, Effenberger T, Trautner C, Buhl R. Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature. Eur Respir J. 2018;52(4):1800703. doi:https://doi.org/10.1183/13993003.00703-2018.
   PubMed Web of Science ®Google Scholar
• Reddel HK, Bateman ED, Becker A, Boulet LP, Cruz AA, Drazen JM, Haahtela T, Hurd SS, Inoue H, de Jongste JC, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 2015;46(3):622–639. doi:https://doi.org/10.1183/13993003.00853-2015.
   PubMed Web of Science ®Google Scholar
• Dusser D, Montani D, Chanez P, de Blic J, Delacourt C, Deschildre A, Devillier P, Didier A, Leroyer C, Marguet C, et al. Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations. Allergy. 2007;62(6):591–604. doi:https://doi.org/10.1111/j.1398-9995.2007.01394.x.
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218–224. doi:https://doi.org/10.1164/rccm.200711-1754OC.
   PubMed Web of Science ®Google Scholar
• Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D’Agostino R, Jr, Castro M, Curran-Everett D, Fitzpatrick AM, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181(4):315–323. doi:https://doi.org/10.1164/rccm.200906-0896OC.
   PubMed Web of Science ®Google Scholar
• Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716–725. doi:https://doi.org/10.1038/nm.2678.
   PubMed Web of Science ®Google Scholar
• Bagnasco D, Povero M, Pradelli L, Brussino L, Rolla G, Caminati M, Menzella F, Heffler E, Canonica GW, Paggiaro P, et al. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life. World Allergy Organ J. 2021;14(2):100509. doi:https://doi.org/10.1016/j.waojou.2021.100509.
   PubMed Web of Science ®Google Scholar
• Puggioni F, Brussino L, Canonica GW, Blasi F, Paggiaro P, Caminati M, Latorre M, Heffler E, Senna G. Frequency of tiotropium bromide use and clinical features of patients with severe asthma in a real-life setting: data from the Severe Asthma Network in Italy (SANI) registry. J Asthma Allergy. 2020;13:599–604. doi:https://doi.org/10.2147/JAA.S274245. eCollection 2020.
   PubMed Web of Science ®Google Scholar
• Senna G, Latorre M, Bugiani M, Caminati M, Heffler E, Morrone D, Paoletti G, Parronchi P, Puggioni F, Blasi F, et al. Sex differences in severe asthma: results from Severe Asthma Network in Italy-SANI. Allergy Asthma Immunol Res. 2021;13(2):219–228. doi:https://doi.org/10.4168/aair.2021.13.2.219.
   PubMed Web of Science ®Google Scholar
• Malipiero G, Paoletti G, Blasi F, Paggiaro P, Senna G, Latorre M, Caminati M, Carpagnano GE, Crimi N, Spanevello A, et al. Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry. Expert Rev Respir Med. 2020;3:1–6. doi:https://doi.org/10.1080/17476348.2021.1840983.
   Web of Science ®Google Scholar
• Canonica GW, Blasi F, Paggiaro P, Senna G, Passalacqua G, Spanevello A, Aliberti S, Bagnasco D, Bonavia M, Bonini M, et al. Oral corticosteroid sparing with biologics in severe asthma: a remark of the Severe Asthma Network in Italy (SANI). World Allergy Organ J. 2020;13(10):100464. doi:https://doi.org/10.1016/j.waojou.2020.100464.
   PubMed Web of Science ®Google Scholar
• Heffler E, Detoraki A, Contoli M, Papi A, Paoletti G, Malipiero G, Brussino L, Crimi C, Morrone D, Padovani M, et al. COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments. Allergy. 2021;76(3):887–892. doi:https://doi.org/10.1111/all.14532.
   PubMed Web of Science ®Google Scholar
• Canonica GW, Malvezzi L, Blasi F, Paggiaro P, Mantero M, Senna G, Heffler E, Severe Asthma Network Italy (SANI). Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: evidences from the Severe Asthma Network Italy (SANI) registry. Respir Med. 2020;166:105947. doi:https://doi.org/10.1016/j.rmed.2020.105947. Epub 2020 Apr 2.
   PubMed Web of Science ®Google Scholar
• Canonica GW, Colombo GL, Bruno GM, Di Matteo S, Martinotti C, Blasi F, Bucca C, Crimi N, Paggiaro P, Pelaia G, et al. Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. World Allergy Organ J. 2019;12(1):100007. doi:https://doi.org/10.1016/j.waojou.2018.12.001.
   PubMed Web of Science ®Google Scholar
• Senna G, Guerriero M, Paggiaro PL, Blasi F, Caminati M, Heffler E, Latorre M, Canonica GW, SANI. SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma. Clin Mol Allergy. 2017;15:9. doi:https://doi.org/10.1186/s12948-017-0065-4.
   PubMedGoogle Scholar
• Chen W, FitzGerald JM, Lynd LD, Sin DD, Sadatsafavi M. Long-term trajectories of mild asthma in adulthood and risk factors of progression. J Allergy Clin Immunol Pract. 2018;6(6):2024–2032.e5. doi:https://doi.org/10.1016/j.jaip.2018.04.027.
   PubMed Web of Science ®Google Scholar
• Boulet LP, Reddel HK, Brightling C, Brusselle G. GINA fosters World Asthma Day 2020 to prevent asthma deaths. Am J Physiol Lung Cell Mol Physiol. 2020;318(5):L998–L1000. doi:https://doi.org/10.1152/ajplung.00075.2020.
   PubMed Web of Science ®Google Scholar